AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand. The vaccine — called Vaxzevria and ...

AstraZeneca has agreed to pay up to $2 billion for an experimental pill used to treat obesity and type 2 diabetes—the latest pharmaceutical firm to bet on treatment similar to popular weight ...

AstraZeneca Plc agreed to buy Icosavax Inc. for as much as $1.1 billion to gain a developer of innovative vaccines for respiratory viruses. Astra offered $15 in cash for each of Icosavax’s ...

A replacement for a key COVID-19 antibody drug that has been used to protect immunocompromised Americans could be available within months, executives for drugmaker AstraZeneca said Thursday ...

Sees $80 bln in 2030 revenue by 2030 Shares rise 1.5% Company to launch 20 new medicines by 2030 Says "many" new drugs have $5 bln peak year revenue potential May 21 (Reuters) - AstraZeneca (AZN.L ...